Teladoc Health, Inc. — Director's Dealing 2023

Dec 5, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Teladoc Health, Inc. (TDOC)
CIK: 0001477449
Period of Report: 2023-12-01

Reporting Person: Nanis Nikolaos P. (Chief Technology Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	63428	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$32.62	2032-05-31	Common Stock (21162)		Direct
Restricted Stock Units	$		Common Stock (467)		Direct
Restricted Stock Units	$		Common Stock (568)		Direct
Restricted Stock Units	$		Common Stock (3033)		Direct
Restricted Stock Units	$		Common Stock (6260)		Direct
Restricted Stock Units	$		Common Stock (9862)		Direct
Restricted Stock Units	$		Common Stock (13021)		Direct

Footnotes

F1: The option vested as to one-third of the shares on June 1, 2023. The remainder of the shares vest in 24 substantially equal monthly installments thereafter.

F2: On March 2, 2021, the reporting person was granted 1,400 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

F3: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F4: On August 10, 2021, the reporting person was granted 1,703 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

F5: On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6: On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F7: On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F8: On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.